Fibroblast growth factor homologous factors (FHFs) are an auxiliary subunit of the cardiac voltage-gated sodium channel. We found that FHFs can inhibit the arrhythmogenic late sodium current (INa,L) in an isoform-specific manner, and engineered an FHF-based cell-penetrating peptide that acts as an inhibitor of INa,L and opens avenues for developing future therapeutics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Remme, C. A., Wilde, A. A. M. & Bezzina, C. R. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc. Med. 18, 78–87 (2008). A review article that summaries variable clinical manifestations of cardiac NaV1.5 channelopathies.
Horvath, B. & Bers, D. The late sodium current in heart failure: pathophysiology and clinical relevance. ESC Heart Fail. 1, 26–40 (2014). A review article that presents recent advances in understanding of the role of INa,L in cardiac pathophysiology.
Abrams, J. M. et al. Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin-binding-deficient channels. JCI Insight 5, e141736 (2020). A paper that shows that FHF inhibits INa,L.
Goldfarb, M. Voltage gated sodium channel associated proteins and alternative mechanisms of inactivation and block. Cell. Mol. Life Sci. 69, 1067–1076 (2012). A review article that highlights the role of FHF in tuning NaV1.5 inactivation.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Chakouri, N. et al. Fibroblast growth factor homologous factors serve as a molecular rheostat in tuning arrhythmogenic cardiac late sodium current. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-022-00060-6 (2022).
Rights and permissions
About this article
Cite this article
Leveraging FHF modulation to inhibit arrhythmogenic late sodium current. Nat Cardiovasc Res 1, 548–549 (2022). https://doi.org/10.1038/s44161-022-00077-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-022-00077-x